317 related articles for article (PubMed ID: 19837868)
1. Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: a systematic review.
Tegethoff M; Pryce C; Meinlschmidt G
Endocr Rev; 2009 Dec; 30(7):753-89. PubMed ID: 19837868
[TBL] [Abstract][Full Text] [Related]
2. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk.
Braun T; Challis JR; Newnham JP; Sloboda DM
Endocr Rev; 2013 Dec; 34(6):885-916. PubMed ID: 23970762
[TBL] [Abstract][Full Text] [Related]
3. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids.
Kapoor A; Petropoulos S; Matthews SG
Brain Res Rev; 2008 Mar; 57(2):586-95. PubMed ID: 17716742
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
5. Fetal glucocorticoid exposure and hypothalamo-pituitary-adrenal (HPA) function after birth.
Matthews SG; Owen D; Kalabis G; Banjanin S; Setiawan EB; Dunn EA; Andrews MH
Endocr Res; 2004 Nov; 30(4):827-36. PubMed ID: 15666833
[TBL] [Abstract][Full Text] [Related]
6. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations.
Waffarn F; Davis EP
Am J Obstet Gynecol; 2012 Dec; 207(6):446-54. PubMed ID: 22840973
[TBL] [Abstract][Full Text] [Related]
7. Prenatal glucocorticoid modifies hypothalamo-pituitary-adrenal regulation in prepubertal guinea pigs.
Dean F; Yu C; Lingas RI; Matthews SG
Neuroendocrinology; 2001 Mar; 73(3):194-202. PubMed ID: 11307038
[TBL] [Abstract][Full Text] [Related]
8. Prenatal xenobiotic exposure and intrauterine hypothalamus-pituitary-adrenal axis programming alteration.
Zhang C; Xu D; Luo H; Lu J; Liu L; Ping J; Wang H
Toxicology; 2014 Nov; 325():74-84. PubMed ID: 25194749
[TBL] [Abstract][Full Text] [Related]
9. The impact of maternal synthetic glucocorticoid administration in late pregnancy on fetal and early neonatal hypothalamic-pituitary-adrenal axes regulatory genes is dependent upon dose and gestational age at exposure.
Li S; Moss TJ; Nitsos I; Matthews SG; Challis JR; Newnham JP; Sloboda DM
J Dev Orig Health Dis; 2013 Feb; 4(1):77-89. PubMed ID: 25080184
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: a systematic review.
Carpenter T; Grecian SM; Reynolds RM
J Dev Orig Health Dis; 2017 Apr; 8(2):244-255. PubMed ID: 28103963
[TBL] [Abstract][Full Text] [Related]
11. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs.
Banjanin S; Kapoor A; Matthews SG
J Physiol; 2004 Jul; 558(Pt 1):305-18. PubMed ID: 15146051
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
[TBL] [Abstract][Full Text] [Related]
13. The fetal and neonatal hypothalamic-pituitary-adrenal axis.
Ng PC
Arch Dis Child Fetal Neonatal Ed; 2000 May; 82(3):F250-4. PubMed ID: 10794797
[No Abstract] [Full Text] [Related]
14. [Steroid therapy and adrenal function].
Cota D; Ceroni L; Pasquali R
Recenti Prog Med; 2000 Nov; 91(11):594-600. PubMed ID: 11125954
[TBL] [Abstract][Full Text] [Related]
15. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome.
Weinberg J; Sliwowska JH; Lan N; Hellemans KG
J Neuroendocrinol; 2008 Apr; 20(4):470-88. PubMed ID: 18266938
[TBL] [Abstract][Full Text] [Related]
16. Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function.
Iqbal M; Moisiadis VG; Kostaki A; Matthews SG
Endocrinology; 2012 Jul; 153(7):3295-307. PubMed ID: 22564976
[TBL] [Abstract][Full Text] [Related]
17. Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice.
Liang G; Chen M; Pan XL; Zheng J; Wang H
Exp Toxicol Pathol; 2011 Nov; 63(7-8):607-11. PubMed ID: 20627497
[TBL] [Abstract][Full Text] [Related]
18. Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: influences on maternal and fetal outcomes.
Duthie L; Reynolds RM
Neuroendocrinology; 2013; 98(2):106-15. PubMed ID: 23969897
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids and fetal programming part 1: Outcomes.
Moisiadis VG; Matthews SG
Nat Rev Endocrinol; 2014 Jul; 10(7):391-402. PubMed ID: 24863382
[TBL] [Abstract][Full Text] [Related]
20. Prenatal bisphenol a exposure and dysregulation of infant hypothalamic-pituitary-adrenal axis function: findings from the APrON cohort study.
Giesbrecht GF; Ejaredar M; Liu J; Thomas J; Letourneau N; Campbell T; Martin JW; Dewey D;
Environ Health; 2017 May; 16(1):47. PubMed ID: 28526030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
